Market Exclusive

Analyst Downgrades – Arcturus Therapeutics (NASDAQ:ARCT) Stock Gets Downgraded By Ladenburg Thalmann Financial Services from Buy to Neutral

Analyst Ratings For Arcturus Therapeutics (NASDAQ:ARCT)

Today, Arcturus Therapeutics (NASDAQ:ARCT) stock was downgraded by Ladenburg Thalmann Financial Services from Buy to Neutral.

Some recent analyst ratings include


Recent Trading Activity for Arcturus Therapeutics (NASDAQ:ARCT)
Shares of Arcturus Therapeutics closed the previous trading session at 5.50 down -0.15 2.66% with shares trading hands.

Exit mobile version